Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-16T01:04:35.827Z Has data issue: false hasContentIssue false
  • English
  • Français

Essential fatty acids, behaviour & aggression

Published online by Cambridge University Press:  11 September 2013

Get access

In a nutshell

There is good reason to believe the EFAs can affect behaviour, including aggressive or disturbed behaviour, in adults and in children especially.

A number of RCTs suggest that EFA supplements may be able to improve such behaviour, e.g. in attention deficit disorders. But more evidence is needed before we can be sure of when, how and what.

Type
Brief Report
Information
Arbor Clinical Nutrition Updates , Volume 242 , February 2006 , pp. 1 - 3
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Schnoll, R. et al. Nutrition in the treatment of attention-deficit hyperactivity disorder: a neglected but important aspect. Appl Psychophysiol Biofeedback. 2003 Mar;28(1):63–75.Google Scholar
2. Gesch, CB. et al. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. Br J Psychiatry. 2002 Jul;181:22–8.Google Scholar
3. Schoenthaler, S. et al. The Effect of Randomized Vitamin-Mineral Supplementation on Violent and Non-violent Antisocial Behavior Among Incarcerated Juveniles J of Nutr Environ Med. 1997;7(4):343–352.Google Scholar
4. Schoenthaler, SJ. et al. The effect of vitamin-mineral supplementation on juvenile delinquency among American schoolchildren: a randomized, double-blind placebo-controlled trial. J Altern Complement Med. 2000 Feb;6(1):7–17.CrossRefGoogle ScholarPubMed
5. Hallahan, B. et al. Essential fatty acids and mental health. Br J Psychiatry. 2005 Apr;186:275–7.Google Scholar
6. Helman, A. Baby formula and infant brain development. Arbor Clin Nutr Upd 2001;91:1–2 Google Scholar
7. Yoshida, S. et al. Pathophysiological effects of dietary essential fatty acid balance on neural systems. Jpn J Pharmacol. 1998 May;77(1):11–22.Google Scholar
8. Larque, E. et al. Perinatal supply and metabolism of long-chain polyunsaturated fatty acids: importance for the early development of the nervous system. Ann N Y Acad Sci. 2002 Jun;967:299–310.Google Scholar
9. Vinod, KY. et al. Endocannabinoid lipids and mediated system: implications for alcoholism and neuropsychiatric disorders. Life Sci. 2005 Aug 19;77(14):1569–83.Google Scholar
10. Fride, E. Endocannabinoids in the central nervous system--an overview. Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2–3):221–33.CrossRefGoogle ScholarPubMed
11. Richardson, AJ. Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Lipids. 2004 Dec;39(12):1215–22.Google Scholar
12. Richardson, AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids. 2004 Apr;70(4):383–90.Google Scholar
13. Richardson, AJ. et al. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2000 Jul–Aug;63(1–2):79–87.Google Scholar
14. Burgess, JR. et al. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr. 2000 Jan;71(1 Suppl):327S–30S.Google Scholar
15. Stevens, LJ. et al. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav. 1996 Apr–May;59(4–5):915–20.Google Scholar
16. Mahadik, SP. et al. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):463–93.CrossRefGoogle ScholarPubMed
17. Strassnig, M. et al. Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophr Res. 2005 Jul 15;76(2–3):343–51.Google Scholar
18. Huan, M. et al. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry. 2004 Oct 1;56(7):490–6.Google Scholar
19. Colin, A. et al. [Lipids, depression and suicide] Encephale. 2003 Jan–Feb;29(1):49–58.Google Scholar
20. Golomb, BA. et al. Low cholesterol and violent crime. J Psychiatr Res. 2000 Jul–Oct;34(4–5):301–9.Google Scholar
21. Hibbeln, JR. et al. A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. Biol Psychiatry. 1998 Aug 15;44(4):243–9.Google Scholar
22. McCann, JC. et al. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr. 2005 Aug;82(2):281–95.Google Scholar
23. Mostofsky, DI. Models and methods for studying behavior in polyunsaturated fatty acid research. Lipids. 2001 Sep;36(9):913–7.Google Scholar
24. Anon. The Omega wave. http://www.bbc.co.uk/science/humanbody/mind/articles/intelligenceandmemory/omega_three.shtml Google Scholar
25. Stevens, L. et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids. 2003 Oct;38(10):1007–21.Google Scholar
26. Voigt, RG. et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr. 2001 Aug;139(2):189–96.Google Scholar
27. Hirayama, S. et al. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder – a placebo-controlled double-blind study. Eur J Clin Nutr. 2004 Mar;58(3):467–73.Google Scholar
28. Hamazaki, T. et al. Docosahexaenoic acid does not affect aggression of normal volunteers under nonstressful conditions. A randomized, placebo-controlled, double-blind study. Lipids. 1998 Jul;33(7):663–7.CrossRefGoogle Scholar
29. HamazakI, T. et al. The effect of docosahexaenoic acid on aggression in elderly Thai subjects--a placebo-controlled double-blind study. Nutr Neurosci. 2002 Feb;5(1):37–41.Google Scholar
30. Hamazaki, T. et al. Effect of docosahexaenoic acid on hostility. World Rev Nutr Diet. 2001;88:47–52.CrossRefGoogle ScholarPubMed
31. Hamazaki, T. et al. Anti-stress effects of DHA. Biofactors. 2000;13(1–4):41–5.Google Scholar
32. Zanarini, MC. et al. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry. 2003 Jan;160(1):167–9.Google Scholar
33. Stoll, AL. et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999 May;56(5):407–12.Google Scholar
34. Nemets, B. et al. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002 Mar;159(3):477–9.Google Scholar
35. Bradbury, J. et al. An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot). Nutr J. 2004 Nov 28;3:20.CrossRefGoogle Scholar
36. Yehuda, S. et al. Mixture of essential fatty acids lowers test anxiety. Nutr Neurosci. 2005 Aug;8(4):265–7.Google Scholar
37. Mills, DE. et al. Dietary fatty acid supplementation alters stress reactivity and performance in man. J Hum Hypertens. 1989 Apr;3(2):111–6.Google Scholar
38. Maes, M. et al. In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry. 2000 May 15;47(10):910–20.Google Scholar